0.05),respectively,and the cost-effectiveness ratios of 3 groups were 487.20,453.09,and 581.21,respectively.CONCLUSION:Quetiapine is the optimal one for schizophrenia in pharmacoeconomics.
0.05),but the incidence of adverse effects in ziprasidone group was markedly lower than in perphena-zine group.CONCLUSION: As compared with perphenazine,ziprasidone is more effective and safe with less side effects in the treatment of schizophrenia.
Result Analysis
Print
Save
E-mail